A citation-based method for searching scientific literature

Toshihiro Dohi, Katsuya Morita, Tomoya Kitayama, Naoyo Motoyama, Norimitsu Morioka. Pharmacol Ther 2009
Times Cited: 76



Mario Mezler, Wilfried Hornberger, Reinhold Mueller, Martin Schmidt, Willi Amberg, Wilfried Braje, Michael Ochse, Hans Schoemaker, Berthold Behl. Mol Pharmacol 2008
Times Cited: 46




List of shared articles



Times cited


Guide to Receptors and Channels (GRAC), 5th edition.
Stephen P H Alexander, Alistair Mathie, John A Peters. Br J Pharmacol 2011
692

MS binding assays for GlyT1 based on Org24598 as nonlabelled reporter ligand.
Thomas M Ackermann, Karuna Bhokare, Georg Höfner, Klaus T Wanner. Neuropharmacology 2019
4

SLC6 neurotransmitter transporters: structure, function, and regulation.
Anders S Kristensen, Jacob Andersen, Trine N Jørgensen, Lena Sørensen, Jacob Eriksen, Claus J Loland, Kristian Strømgaard, Ulrik Gether. Pharmacol Rev 2011
478

Synthesis and evaluation of 2-chloro N-[(S)-{(S)-1-[11 C]methylpiperidin-2-yl} (phenyl)methyl]3-trifluoromethyl-benzamide ([11 C]N-methyl-SSR504734) as a PET radioligand for glycine transporter 1.
Takeshi Fuchigami, Akihiro Takano, Balázs Gulyás, Zhisheng Jia, Sjoerd J Finnema, Jan D Andersson, Ryuji Nakao, Yasuhiro Magata, Mamoru Haratake, Morio Nakayama,[...]. EJNMMI Res 2012
3




Synthesis and Biological Evaluation of N-((1-(4-(Sulfonyl)piperazin-1-yl)cycloalkyl)methyl)benzamide Inhibitors of Glycine Transporter-1.
Christopher L Cioffi, Shuang Liu, Mark A Wolf, Peter R Guzzo, Kashinath Sadalapure, Visweswaran Parthasarathy, David T J Loong, Jun-Ho Maeng, Edmund Carulli, Xiao Fang,[...]. J Med Chem 2016
6

The Glycine Receptor-A Functionally Important Primary Brain Target of Ethanol.
Bo Söderpalm, Helga H Lidö, Mia Ericson. Alcohol Clin Exp Res 2017
23

Reversible inhibition of the glycine transporter GlyT2 circumvents acute toxicity while preserving efficacy in the treatment of pain.
A Mingorance-Le Meur, P Ghisdal, B Mullier, P De Ron, P Downey, C Van Der Perren, V Declercq, S Cornelis, M Famelart, J Van Asperen,[...]. Br J Pharmacol 2013
35